Synthesis and evaluation of conformationally constrained peptide analogues as the Src SH3 domain binding ligands
Src kinase activity is regulated by the interaction of SH3 domain with protein sequences that are rich in proline residues. Identification of more potent SH3 domain binding ligands that can regulate Src kinase activity is a subject of major interest. Conformationally constrained peptides have been p...
Saved in:
Published in | Biochimie Vol. 92; no. 9; pp. 1153 - 1163 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
France
Elsevier Masson SAS
01.09.2010
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Src kinase activity is regulated by the interaction of SH3 domain with protein sequences that are rich in proline residues. Identification of more potent SH3 domain binding ligands that can regulate Src kinase activity is a subject of major interest. Conformationally constrained peptides have been previously used for improving the binding potency of the Src SH2 domain binding peptide ligands and peptide substrates of the substrate-binding site of Src. A series of peptide analogues of Ac-VSLARRPLPPLP (
1, Ac-VSL12,
K
d = 0.34 μM) were synthesized by introducing conformational constraints to improve the binding affinity towards the Src SH3 domain. Peptides synthesized through cyclization between
N-terminal to
C-terminal [VSLARRPLPPLP] or
N-terminal to side chain flanking residues (i.e., [
βAVS]LARRPLPPLP and [VSLE]RRPLPPLP) exhibited at least 6.4-fold less binding affinity (
K
d = 2.19–4.85 μM) when compared to
1. The data suggest upon N-terminal cyclization with C-terminal or flanking residues, the interactions of the amino acids in the core RPLPPLP reduce significantly with the residues within the Src SH3 domain. Conformationally constrained peptide V[SLARRPLPPLP] (
5) was synthesized through cyclization of C-terminal to the serine side chain and displayed a comparable binding affinity (
K
d = 0.35 μM) towards the Src SH3 domain versus that of
1. Thus, this template may be used to optimize and generate more potent analogues with higher stability. |
---|---|
AbstractList | Src kinase activity is regulated by the interaction of SH3 domain with protein sequences that are rich in proline residues. Identification of more potent SH3 domain binding ligands that can regulate Src kinase activity is a subject of major interest. Conformationally constrained peptides have been previously used for improving the binding potency of the Src SH2 domain binding peptide ligands and peptide substrates of the substrate-binding site of Src. A series of peptide analogues of Ac-VSLARRPLPPLP (
1, Ac-VSL12,
K
d = 0.34 μM) were synthesized by introducing conformational constraints to improve the binding affinity towards the Src SH3 domain. Peptides synthesized through cyclization between
N-terminal to
C-terminal [VSLARRPLPPLP] or
N-terminal to side chain flanking residues (i.e., [
βAVS]LARRPLPPLP and [VSLE]RRPLPPLP) exhibited at least 6.4-fold less binding affinity (
K
d = 2.19–4.85 μM) when compared to
1. The data suggest upon N-terminal cyclization with C-terminal or flanking residues, the interactions of the amino acids in the core RPLPPLP reduce significantly with the residues within the Src SH3 domain. Conformationally constrained peptide V[SLARRPLPPLP] (
5) was synthesized through cyclization of C-terminal to the serine side chain and displayed a comparable binding affinity (
K
d = 0.35 μM) towards the Src SH3 domain versus that of
1. Thus, this template may be used to optimize and generate more potent analogues with higher stability. Src kinase activity is regulated by the interaction of SH3 domain with protein sequences that are rich in proline residues. Identification of more potent SH3 domain binding ligands that can regulate Src kinase activity is a subject of major interest. Conformationally constrained peptides have been previously used for improving the binding potency of the Src SH2 domain binding peptide ligands and peptide substrates of the substrate-binding site of Src. A series of peptide analogues of Ac-VSLARRPLPPLP (1, Ac-VSL12, Kd=0.34 microM) were synthesized by introducing conformational constraints to improve the binding affinity towards the Src SH3 domain. Peptides synthesized through cyclization between N-terminal to C-terminal [VSLARRPLPPLP] or N-terminal to side chain flanking residues (i.e., [(beta)AVS]LARRPLPPLP and [VSLE]RRPLPPLP) exhibited at least 6.4-fold less binding affinity (Kd=2.19-4.85 microM) when compared to 1. The data suggest upon N-terminal cyclization with C-terminal or flanking residues, the interactions of the amino acids in the core RPLPPLP reduce significantly with the residues within the Src SH3 domain. Conformationally constrained peptide V[SLARRPLPPLP] (5) was synthesized through cyclization of C-terminal to the serine side chain and displayed a comparable binding affinity (Kd=0.35 microM) towards the Src SH3 domain versus that of 1. Thus, this template may be used to optimize and generate more potent analogues with higher stability. Src kinase activity is regulated by the interaction of SH3 domain with protein sequences that are rich in proline residues. Identification of more potent SH3 domain binding ligands that can regulate Src kinase activity is a subject of major interest. Conformationally constrained peptides have been previously used for improving the binding potency of the Src SH2 domain binding peptide ligands and peptide substrates of the substrate-binding site of Src. A series of peptide analogues of Ac-VSLARRPLPPLP (1, Ac-VSL12, Kd=0.34 microM) were synthesized by introducing conformational constraints to improve the binding affinity towards the Src SH3 domain. Peptides synthesized through cyclization between N-terminal to C-terminal [VSLARRPLPPLP] or N-terminal to side chain flanking residues (i.e., [(beta)AVS]LARRPLPPLP and [VSLE]RRPLPPLP) exhibited at least 6.4-fold less binding affinity (Kd=2.19-4.85 microM) when compared to 1. The data suggest upon N-terminal cyclization with C-terminal or flanking residues, the interactions of the amino acids in the core RPLPPLP reduce significantly with the residues within the Src SH3 domain. Conformationally constrained peptide V[SLARRPLPPLP] (5) was synthesized through cyclization of C-terminal to the serine side chain and displayed a comparable binding affinity (Kd=0.35 microM) towards the Src SH3 domain versus that of 1. Thus, this template may be used to optimize and generate more potent analogues with higher stability.Src kinase activity is regulated by the interaction of SH3 domain with protein sequences that are rich in proline residues. Identification of more potent SH3 domain binding ligands that can regulate Src kinase activity is a subject of major interest. Conformationally constrained peptides have been previously used for improving the binding potency of the Src SH2 domain binding peptide ligands and peptide substrates of the substrate-binding site of Src. A series of peptide analogues of Ac-VSLARRPLPPLP (1, Ac-VSL12, Kd=0.34 microM) were synthesized by introducing conformational constraints to improve the binding affinity towards the Src SH3 domain. Peptides synthesized through cyclization between N-terminal to C-terminal [VSLARRPLPPLP] or N-terminal to side chain flanking residues (i.e., [(beta)AVS]LARRPLPPLP and [VSLE]RRPLPPLP) exhibited at least 6.4-fold less binding affinity (Kd=2.19-4.85 microM) when compared to 1. The data suggest upon N-terminal cyclization with C-terminal or flanking residues, the interactions of the amino acids in the core RPLPPLP reduce significantly with the residues within the Src SH3 domain. Conformationally constrained peptide V[SLARRPLPPLP] (5) was synthesized through cyclization of C-terminal to the serine side chain and displayed a comparable binding affinity (Kd=0.35 microM) towards the Src SH3 domain versus that of 1. Thus, this template may be used to optimize and generate more potent analogues with higher stability. |
Author | Parang, Keykavous Sun, Gongqin Tiwari, Rakesh Brown, Alex Narramaneni, Seetha |
Author_xml | – sequence: 1 givenname: Rakesh surname: Tiwari fullname: Tiwari, Rakesh organization: Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, 41 Lower College Road, Kingston, RI 02881, USA – sequence: 2 givenname: Alex surname: Brown fullname: Brown, Alex organization: Department of Cell and Molecular Biology, University of Rhode Island, Kingston, RI 02881, USA – sequence: 3 givenname: Seetha surname: Narramaneni fullname: Narramaneni, Seetha organization: Department of Cell and Molecular Biology, University of Rhode Island, Kingston, RI 02881, USA – sequence: 4 givenname: Gongqin surname: Sun fullname: Sun, Gongqin organization: Department of Cell and Molecular Biology, University of Rhode Island, Kingston, RI 02881, USA – sequence: 5 givenname: Keykavous surname: Parang fullname: Parang, Keykavous email: kparang@uri.edu organization: Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, 41 Lower College Road, Kingston, RI 02881, USA |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/20109515$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkUtLJDEUhcPgMLbO_INBsnNV7U1XdT1cCCLjAwQXPbMOedy0aVJJmVQL_e8n1a0bFwoXQi7nOzc594Qc-eCRkN8M5gxYfbGZSxvUs50vILeA5Wq-kRmry7aoWVsekRmUAEUHbXVMTlLaAMASFt0Pcjwh3ZItZ2RY7fz4jMkmKrym-CrcVow2eBoMVcGbEPv9XTi3mxppjMJ61HTAYbQaMyZcWG8xGySaregqKrq6L6kOfVZSab22fk2dXecJ6Sf5boRL-OvtPCX_bv_8vbkvHp_uHm6uHwtVQTMWWGGras3QIFQSFtCikYx1ymBb1ZUBZAtkkukOpK6Nyp-UDSt1KRpTGrksT8n5wXeI4SW_buS9TQqdEx7DNvGm6nIcddtk5dmbcit71HyIthdxx99DyoLLg0DFkFJEw5Ud96FMWTjOgE8b4Rt-2Mie5MByTe7VB_jd_wvs6oBhzujVYuRJWfQKtY2oRq6D_dzgP6GyqRY |
CitedBy_id | crossref_primary_10_1016_j_bmcl_2011_05_010 crossref_primary_10_1016_j_pharmthera_2017_02_014 crossref_primary_10_1016_j_bmc_2012_09_057 crossref_primary_10_1371_journal_pone_0261696 crossref_primary_10_1016_j_bmcl_2011_01_047 crossref_primary_10_1002_cmdc_201600387 crossref_primary_10_1016_j_ejmech_2011_07_050 crossref_primary_10_1186_2008_2231_20_100 |
ContentType | Journal Article |
Copyright | 2010 Elsevier Masson SAS Copyright (c) 2010 Elsevier Masson SAS. All rights reserved. |
Copyright_xml | – notice: 2010 Elsevier Masson SAS – notice: Copyright (c) 2010 Elsevier Masson SAS. All rights reserved. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1016/j.biochi.2010.01.017 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Engineering Anatomy & Physiology Chemistry |
EISSN | 1638-6183 |
EndPage | 1163 |
ExternalDocumentID | 20109515 10_1016_j_biochi_2010_01_017 S0300908410000350 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- --K --M -~X .GJ .~1 0R~ 1B1 1RT 1~. 1~5 23N 4.4 457 4G. 53G 5GY 5VS 6J9 7-5 71M 8P~ 9JM AABNK AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AAXUO ABFNM ABFRF ABGSF ABJNI ABMAC ABUDA ABXDB ABYKQ ACDAQ ACGFO ACGFS ACIUM ACRLP ADBBV ADEZE ADMUD ADUVX AEBSH AEFWE AEHWI AEKER AENEX AFKWA AFTJW AFXIZ AGHFR AGRDE AGUBO AGYEJ AHHHB AI. AIEXJ AIKHN AITUG AJBFU AJOXV ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC CS3 DOVZS DU5 EBS EFJIC EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HLW HVGLF HZ~ H~9 IHE J1W KOM LX3 M41 MO0 N9A O-L O9- OAUVE OZT P-8 P-9 P2P PC. Q38 R2- RIG ROL RPZ SBG SCC SDF SDG SDP SES SEW SSU SSZ T5K TWZ VH1 WUQ Y6R ZGI ZXP ~02 ~G- ~KM AAHBH AATTM AAXKI AAYWO AAYXX ABWVN ACRPL ACVFH ADCNI ADNMO AEIPS AEUPX AFJKZ AFPUW AGCQF AGQPQ AGRNS AIGII AIIUN AKBMS AKRWK AKYEP ANKPU BNPGV CITATION SSH CGR CUY CVF ECM EFKBS EIF NPM 7X8 |
ID | FETCH-LOGICAL-c407t-e4e8c6d1efe04b0208efb119cfe8464f0e12e1b1d90bd6fc084b713d3a7f3fb53 |
IEDL.DBID | AIKHN |
ISSN | 0300-9084 1638-6183 |
IngestDate | Thu Jul 10 18:27:44 EDT 2025 Mon Jul 21 05:38:38 EDT 2025 Thu Apr 24 23:07:00 EDT 2025 Tue Jul 01 00:39:01 EDT 2025 Fri Feb 23 02:29:15 EST 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 9 |
Keywords | SH3 domain Fluorescence polarization c-Src VSL12 Peptide synthesis Conformationally constrained peptides |
Language | English |
License | https://www.elsevier.com/tdm/userlicense/1.0 Copyright (c) 2010 Elsevier Masson SAS. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c407t-e4e8c6d1efe04b0208efb119cfe8464f0e12e1b1d90bd6fc084b713d3a7f3fb53 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://digitalcommons.chapman.edu/context/pharmacy_articles/article/1151/viewcontent/auto_convert.pdf |
PMID | 20109515 |
PQID | 749005687 |
PQPubID | 23479 |
PageCount | 11 |
ParticipantIDs | proquest_miscellaneous_749005687 pubmed_primary_20109515 crossref_citationtrail_10_1016_j_biochi_2010_01_017 crossref_primary_10_1016_j_biochi_2010_01_017 elsevier_sciencedirect_doi_10_1016_j_biochi_2010_01_017 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2010-09-01 |
PublicationDateYYYYMMDD | 2010-09-01 |
PublicationDate_xml | – month: 09 year: 2010 text: 2010-09-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | France |
PublicationPlace_xml | – name: France |
PublicationTitle | Biochimie |
PublicationTitleAlternate | Biochimie |
PublicationYear | 2010 |
Publisher | Elsevier Masson SAS |
Publisher_xml | – name: Elsevier Masson SAS |
References | Steinauer, White (bib24) 1994 Feng, Kasahara, Rickles, Schreiber (bib14) 1995; 92 Smith, Bartlett (bib18) 1998; 120 Shen, Batzer, Koehler, Polakis, Schlessinger, Lydon, Moran (bib8) 1999; 18 Thomas, Brugge (bib1) 1997; 13 Cao, Tay, Guy, Tan (bib9) 1996; 16 Khan, Parrish, Fraser, Smith, Bartlett, James (bib17) 1998; 37 Feng, Chen, Yu, Simon, Schreiber (bib12) 1994; 266 Lynch, Loiacono, Tiong, Adams, MacNeil (bib23) 1997; 247 Xu, Harrison, Eck (bib4) 1997; 385 Davidson, Lubman, Rose, Waksman, Martin (bib19) 2002; 124 Sicheri, Moarefi, Kuriyan (bib6) 1997; 385 Roskoski (bib7) 2005; 331 Songyang, Shoelson, Chaudhuri (bib5) 1993; 72 Ferguson, Fan, Mukherjee, Luo, Khan, Ferreon, Hilser, Shope, Fox (bib15) 2004; 13 Rickles, Botfield, Xiao-Mai, Henry, Brugge, Zoller (bib13) 1995; 92 Szewczuk, Stefanowicz, Wilczynski, Staszewska, Siemion, Zimecki, Wieczorek (bib20) 2004; 74 Warmuth, Damoiseaux, Liu, Fabbro, Gray (bib2) 2003; 9 Donaldson, Dempsey, Reddy, Bouton, Coffey, Hanks (bib10) 2000; 256 Ngugen-Hai, Ye, Sun, Parang (bib21) 2004; 47 Kumar, Ye, Wang, Lin, Sun, Parang (bib22) 2006; 49 Pawson (bib3) 1995; 373 Yu, Chen, Feng, Dalgarno, Brauer, Schreiber (bib11) 1994; 76 Humphrey, Chamberlin (bib16) 1997; 97 |
References_xml | – volume: 266 start-page: 1241 year: 1994 end-page: 1247 ident: bib12 article-title: Two binding orientations for peptides to the Src SH3 domain: development of a general model for SH3–ligand interactions publication-title: Science – volume: 385 start-page: 595 year: 1997 end-page: 602 ident: bib4 article-title: Three dimensional structure of the tyrosine kinase c-Src publication-title: Nature – start-page: 689 year: 1994 end-page: 692 ident: bib24 article-title: Innovations and perspectives in solid phase synthesis publication-title: 3rd International Symposium – volume: 385 start-page: 602 year: 1997 end-page: 609 ident: bib6 article-title: Crystal structure of the Src-family tyrosine kinase Hck publication-title: Nature – volume: 120 start-page: 4622 year: 1998 end-page: 4628 ident: bib18 article-title: Macrocyclic inhibitors of penicillopepsin. 3. Design, synthesis, and evaluation of an inhibitor bridged between P2 and P1 publication-title: J. Am. Chem. Soc. – volume: 92 start-page: 10909 year: 1995 end-page: 10913 ident: bib13 article-title: Phage display selection of ligand residues important for Src Homology 3 domain binding specificity publication-title: Proc. Natl. Acad. Sci. U.S.A. – volume: 16 start-page: 1595 year: 1996 end-page: 1603 ident: bib9 article-title: Activation and association of Stat3 with Src in v-Src-transformed cell lines publication-title: Mol. Cell. Biol. – volume: 13 start-page: 513 year: 1997 end-page: 609 ident: bib1 article-title: Cellular functions regulated by Src family Kinase publication-title: Annu. Rev. Cell Dev. Biol. – volume: 18 start-page: 4647 year: 1999 end-page: 4653 ident: bib8 article-title: Evidence for SH3 domain directed binding and phosphorylation of Sam68 by Src publication-title: Oncogene – volume: 9 start-page: 2043 year: 2003 end-page: 2059 ident: bib2 article-title: Src family kinases potential targets for the treatment of human cancer and leukemia publication-title: Curr. Pharm. Des. – volume: 74 start-page: 352 year: 2004 end-page: 362 ident: bib20 article-title: Immunosuppressory activity of ubiquitin fragments containing retro-RGD sequence publication-title: Biopolymers – volume: 97 start-page: 2243 year: 1997 end-page: 2266 ident: bib16 article-title: Chemical synthesis of natural product peptides: coupling methods for the incorporation of noncoded amino acids into peptides publication-title: Chem. Rev. – volume: 72 start-page: 767 year: 1993 end-page: 778 ident: bib5 article-title: SH2 domains recognize specific phosphopeptide sequences publication-title: Cell – volume: 13 start-page: 626 year: 2004 end-page: 632 ident: bib15 article-title: Directed discovery of bivalent peptide ligands to an SH3 domain publication-title: Protein Sci. – volume: 331 start-page: 1 year: 2005 end-page: 14 ident: bib7 article-title: Src kinase regulation by phosphorylation and dephosphorylation publication-title: Biochem. Biophys. Res. Commun. – volume: 256 start-page: 168 year: 2000 end-page: 178 ident: bib10 article-title: Crk-associated substrate p130(Cas) interacts with nephrocystin and both proteins localize to cell–cell contacts of polarized epithelial cells publication-title: Exp. Cell Res. – volume: 124 start-page: 205 year: 2002 end-page: 215 ident: bib19 article-title: Calorimetric and structural studies of 1,2,3-trisubstituted cyclopropanes as conformationally constrained peptide inhibitors of Src SH2 domain binding publication-title: J. Am. Chem. Soc. – volume: 76 start-page: 933 year: 1994 end-page: 945 ident: bib11 article-title: Structural basis for the binding of proline-rich peptides to SH3 domains publication-title: Cell – volume: 92 start-page: 12408 year: 1995 end-page: 12415 ident: bib14 article-title: Specific interactions outside the proline-rich core of two classes of Src homology 3 ligands publication-title: Proc. Natl. Acad. Sci. U.S.A. – volume: 247 start-page: 77 year: 1997 end-page: 82 ident: bib23 article-title: A fluorescence polarization based Src-SH2 binding assay publication-title: Anal. Biochem. – volume: 49 start-page: 3395 year: 2006 end-page: 3401 ident: bib22 article-title: Synthesis and structure–activity relationships of linear and conformationally constrained peptide analogues of CIYKYY as Src tyrosine kinase inhibitor publication-title: J. Med. Chem. – volume: 37 start-page: 16839 year: 1998 end-page: 16845 ident: bib17 article-title: Lowering the entropic barrier for binding conformationally flexible inhibitors to enzymes publication-title: Biochemistry – volume: 373 start-page: 573 year: 1995 end-page: 580 ident: bib3 article-title: Protein modules and signalling networks publication-title: Nature – volume: 47 start-page: 3131 year: 2004 end-page: 3141 ident: bib21 article-title: Conformationally constrained peptide analogues of pTyr–Glu–Glu–IIe as inhibitor of the Src SH2 domain binding publication-title: J. Med. Chem. |
SSID | ssj0005029 |
Score | 2.0135279 |
Snippet | Src kinase activity is regulated by the interaction of SH3 domain with protein sequences that are rich in proline residues. Identification of more potent SH3... |
SourceID | proquest pubmed crossref elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1153 |
SubjectTerms | c-Src Conformationally constrained peptides Electrophoresis, Polyacrylamide Gel Fluorescence Polarization Ligands Molecular Structure Peptide synthesis Peptides - chemical synthesis Peptides - chemistry Protein Binding SH3 domain src Homology Domains VSL12 |
Title | Synthesis and evaluation of conformationally constrained peptide analogues as the Src SH3 domain binding ligands |
URI | https://dx.doi.org/10.1016/j.biochi.2010.01.017 https://www.ncbi.nlm.nih.gov/pubmed/20109515 https://www.proquest.com/docview/749005687 |
Volume | 92 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9swDCa69tDtMKzpHt26QodhNzeWrdjyMQhWZC3aS1agN8GSqM1Dagd1eshlv32UbKfroSgwQCeBlGWRlkj5IwnwJSMTItP--y7zPBLkKEcyM0mkhaWtEdOSSx-NfHmVza_F-c3kZgdmQyyMh1X2e3-3p4fduu8Z96s5XlXVeEHqGRexFOGGOvV--16SFhmp9t70-8X86gHpEYdiZZ4-8gxDBF2AeemqMb-qHuPFqeVPnVBPWaDhJDp7A697E5JNu1kewA7WIzic1uQ-327YVxZAneG2fAT7s6Gg2whe_ZN78BBWi01Nxl9btaysLXvI-s0ax8hJ3kY1lsvlxne0oZoEWrbyQBiLxNZd_NAALaOh2OLOsMU8Zba5JUqmqxAxw5bVTx9P_Bauz779mM2jvvxCZMjLW0coUJrMcnQYC-2LeaLTnBfGIRktwsXIE-Sa2yLWNnOGVlaTy2tJ6i51epK-g926qfEDsMzk0iaYWi1RTKSVpXQmEWUhnRWyjI8gHZZcmT43uX-ppRpAaL9VJyjlBaViTi0_gmjLtepyczxDnw_SVI90TNHx8QwnG4SvSGj-n0pZY3PfqlwUPpuqJJL3nVJsp-L5yX6dfPzvx36Clx1YwUPajmF3fXePn8kGWusTeHH6h5_0mv4XScMG4w |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3BTtwwEB0hegAOVbvQllJaHypuYeONN3GOaFW0bYHLgsTNiu1xG7QkK7Ic9tJvZ-wkWzggJKScrBnH8YztGefNDMD3lEyIVPv1XWRZJMhRjmRqRpEWlrZGTAoufTTy-UU6vRK_rsfXGzDpY2E8rLLb-9s9PezWXcuwm83hoiyHM1LPOI-lCDfUiffb3whavn51Hv97hPOIQ6kyTx158j5-LoC8dFmbv2WH8OL0ZM-dT8_Zn-EcOn0HbzsDkp20Y3wPG1gNYPekIuf5dsWOWIB0hrvyAWxN-nJuA9h5lHlwFxazVUWmX1M2rKgs-5_zm9WOkYu8jmks5vOVb2hCLQm0bOFhMBaJrb32oQ4aRl2x2Z1hs2nCbH1LlEyXIV6Gzcs_Ppp4D65Of1xOplFXfCEy5OMtIxQoTWo5OoyF9qU80WnOc-OQTBbhYuQj5JrbPNY2dYZmVpPDa0nmLnF6nHyAzaqu8BOw1GTSjjCxWqIYSysL6cxIFLl0Vsgi3oekn3Jluszk_qPmqoeg3ahWUMoLSsWcnmwfojXXos3M8QJ91ktTPdEwRYfHC5ysF74iofk_KkWF9X2jMpH7XKqSSD62SrEeiucn63X8-dWv_QZb08vzM3X28-L3AWy3sAUPbvsCm8u7ezwka2ipvwZtfwBz2Aen |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Synthesis+and+evaluation+of+conformationally+constrained+peptide+analogues+as+the+Src+SH3+domain+binding+ligands&rft.jtitle=Biochimie&rft.au=Tiwari%2C+Rakesh&rft.au=Brown%2C+Alex&rft.au=Narramaneni%2C+Seetha&rft.au=Sun%2C+Gongqin&rft.date=2010-09-01&rft.pub=Elsevier+Masson+SAS&rft.issn=0300-9084&rft.eissn=1638-6183&rft.volume=92&rft.issue=9&rft.spage=1153&rft.epage=1163&rft_id=info:doi/10.1016%2Fj.biochi.2010.01.017&rft.externalDocID=S0300908410000350 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0300-9084&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0300-9084&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0300-9084&client=summon |